Supplementary Figure 1 from A Phase I Weekly Dosing Study of Brentuximab Vedotin in Patients with Relapsed/Refractory CD30-Positive Hematologic Malignancies

Autor:	Nancy L. Bartlett, Eric L. Sievers, Tae H. Han, Dana A. Kennedy, Anna R. Franklin, Ranjana H. Advani, Joseph D. Rosenblatt, Andres Forero-Torres, Michelle A. Fanale
Rok vydání:	2023
DOI:	10.1158/1078-0432.22447607.v1
Popis:	PDF file - 76KB, Dose proportionality. (A) --- Area under the curve for brentuximab vedotin; (B) --- Area under the curve for free MMAE
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d407c996b7b90e212a488dd2d2adbc https://doi.org/10.1158/1078-0432.22447607.v1 Zobrazit plný text záznamu